Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Hepatitis B Virus Infection Is Associated with Poor Prognosis in Patients with Advanced Non Small Cell Lung Cancer

  • Peng, Jie-Wen (Department of Medical Oncology, Zhongshan Hospital of Sun Yat-sen University, Zhongshan City People's Hospital) ;
  • Liu, Dong-Ying (Department of Clinical Oncology, Jiangmen Hospital of Sun Yat-sen University, Jiangmen City Central Hospital) ;
  • Lin, Gui-Nan (Department of Medical Oncology, Zhongshan Hospital of Sun Yat-sen University, Zhongshan City People's Hospital) ;
  • Xiao, Jian-jun (Department of Medical Oncology, Zhongshan Hospital of Sun Yat-sen University, Zhongshan City People's Hospital) ;
  • Xia, Zhong-Jun (State Key Laboratory of Oncology in South China)
  • Published : 2015.08.03
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Hepatitis B virus (HBV) infection has been reported to be associated with inferior prognosis in hepatocellular and pancreatic carcinoma cases, but has not been studied with respect to non small cell lung cancer (NSCLC). The purpose of this study was to investigate the prognostic significance of HBV infection in advanced NSCLC patients. Materials and Methods: A retrospective cohort of 445 advanced NSCLC patients was recruited at our hospital from January 1, 2003 until August 30, 2014. Serum HBV markers were tested by enzyme-linked immunosorbent assay. COX proportional hazards analysis was used to evaluate associations of HBV infection with overall survival (OS). Results: Of 445 patients who were qualified for the study, 68 patients were positive for HBsAg, also considered as HBV infection. Patients in HBsAg negative group were found to have better OS (12.6 months [12.2-12.9]) than those in HBsAg positive group (11.30 months [10.8-11.9]; p=0.001). Furthermore, COX multivariate analysis identified HBV infection as an independent prognostic factor for OS (HR 0.740 [0.560, 0.978], p=0.034). Conclusions: Our study found that HBsAg-positive status was an independent prognostic factor for OS in patients with advanced NSCLC. Future prospective studies are required to confirm our findings.

Keywords

References

  1. Chen XQ, Peng JW, Lin GN, Li M, Xia ZJ (2012). The effect of prophylactic lamivudine on hepatitis B virus reactivation in HBsAg-positive patients with diffuse large B-cell lymphoma undergoing prolonged rituximab therapy. Med Oncol, 29, 1237-41. https://doi.org/10.1007/s12032-011-9974-0
  2. De Mitri MS, Cassini R, Bernardi M (2010). Hepatitis B virusrelated hepatocarcinogenesis: molecular oncogenic potential of clear or occult infections. Eur J Cancer, 46, 2178-86. https://doi.org/10.1016/j.ejca.2010.03.034
  3. Deng W, Long L, Li JL, et al (2014). Mortality of major cancers in Guangxi, China: sex, age and geographical differences from 1971 and 2005. Asian Pac J Cancer Prev, 15, 1567-74. https://doi.org/10.7314/APJCP.2014.15.4.1567
  4. Engels EA, Cho ER, Jee SH (2010). Hepatitis B virus infection and risk of non-Hodgkin lymphoma in South Korea: a cohort study. Lancet Oncol, 11, 827-34. https://doi.org/10.1016/S1470-2045(10)70167-4
  5. Hatanaka K, Kudo M, Fukunaga T, et al (2007). Clinical characteristics of NonBNonC-HCC: comparison with HBV and HCV related HCC. Intervirology, 50, 24-31. https://doi.org/10.1159/000096309
  6. Hoofnagle JH (2009). Reactivation of hepatitis B. Hepatology, 49, 156-65. https://doi.org/10.1002/hep.22945
  7. Jiang XF, Tang QL, Zou Y, et al (2014). Does HBV infection increase risk of endometrial carcinoma? Asian Pac J Cancer Prev, 15, 713-6. https://doi.org/10.7314/APJCP.2014.15.2.713
  8. Li L, Wu B, Yang LB, Yin GC, Liu JY (2013). Chronic hepatitis B virus infection and risk of pancreatic cancer: a meta-analysis. Asian Pac J Cancer Prev, 14, 275-9. https://doi.org/10.7314/APJCP.2013.14.1.275
  9. Li SL, Su M, Peng T, et al (2013). Clinicopathologic characteristics and prognoses for multicentric occurrence and intrahepatic metastasis in synchronous multinodular hepatocellular carcinoma patients. Asian Pac J Cancer Prev, 14, 217-23. https://doi.org/10.7314/APJCP.2013.14.1.217
  10. Lin GN, Peng JW, Xiao JJ, Liu DY, Xia ZJ (2014). Hepatitis B virus reactivation in hepatitis B surface antigen seropositive patients with metastatic non-small cell lung cancer receiving cytotoxic chemotherapy: the efficacy of preemptive lamivudine and identification of risk factors. Med Oncol, 31, 119. https://doi.org/10.1007/s12032-014-0119-0
  11. Liu J, Yang XL, Li A, et al (2014). Epidemiological patterns of cancer incidence in southern China: based on 6 populationbased cancer registries. Asian Pac J Cancer Prev, 15, 1471-5. https://doi.org/10.7314/APJCP.2014.15.3.1471
  12. Lu FM, Li T, Liu S, Zhuang H (2010). Epidemiology and prevention of hepatitis B virus infection in China. J Viral Hepat, 17, 4-9. https://doi.org/10.1111/j.1365-2893.2010.01266.x
  13. Mason A, Wick M, White H, et al (1993). Hepatitis B virus replication in diverse cell types during chronic hepatitis B virus infection. Hepatology, 18, 781-9. https://doi.org/10.1002/hep.1840180406
  14. Qiu HB, Zhang LY, Zeng ZL, et al (2011). HBV infection decreases risk of liver metastasis in patients with colorectal cancer: a cohort study. World J Gastroenterol, 17, 804-8. https://doi.org/10.3748/wjg.v17.i6.804
  15. She J, Yang P, Hong Q, Bai C (2013). Lung cancer in China: challenges and interventions. Chest, 143, 1117-26. https://doi.org/10.1378/chest.11-2948
  16. Sun Z, Ming L, Zhu X, Lu J (2002). Prevention and control of hepatitis B in China. J Med Virol, 67, 447-50. https://doi.org/10.1002/jmv.10094
  17. Song E, Chen J, Ou Q, et al (2001). Rare occurrence of metastatic colorectal cancers in livers with replicative hepatitis B infection. Am J Surg, 181, 529-33. https://doi.org/10.1016/S0002-9610(01)00634-1
  18. Srivatanakul P, Honjo S, Kittiwatanachot P, el al (2010). Hepatitis viruses and risk of cholangiocarcinoma in northeast Thailand. Asian Pac J Cancer Prev, 11, 985-8.
  19. Tang Y, Sun LG, Liu CS, et al (2013). Clinical analysis of stages of HBV infection in 100 cases of lymphoma. Asian Pac J Cancer Prev, 14, 959-62. https://doi.org/10.7314/APJCP.2013.14.2.959
  20. Wei XL, Qiu MZ, Chen WW, et al (2013). The status of HBV infection influences metastatic pattern and survival in Chinese patients with pancreatic cancer. J Transl Med, 11, 249. https://doi.org/10.1186/1479-5876-11-249
  21. Wu C, Li F, Jiao SC (2012). Prognostic factors for survival of patients with extensive stage small cell lung cancer--a retrospective single institution analysis. Asian Pac J Cancer Prev, 13, 4959-62. https://doi.org/10.7314/APJCP.2012.13.10.4959
  22. Xie WC, Chan MH, Mak KC, Chan WT, He M (2012). Trends in the incidence of 15 common cancers in Hong Kong, 1983-2008. Asian Pac J Cancer Prev, 13, 3911-6. https://doi.org/10.7314/APJCP.2012.13.8.3911
  23. Yeo W, Johnson PJ (2006). Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy. Hepatology, 43, 209-20. https://doi.org/10.1002/hep.21051
  24. Zhao SM, Li HC, Lou H, et al (2001). High Prevalence of HBV in Tibet, China. Asian Pac J Cancer Prev, 2, 299-304.
  25. Zhu F, Li HR, Du GN, Chen JH, Cai SR (2011). Chronic hepatitis B virus infection and pancreatic cancer: a case-control study in southern China. Asian Pac J Cancer Prev, 12, 1405-8.